DESIGN PHARMACEUTICALS Trademark
Trademark Overview
On Tuesday, May 5, 2020, a trademark application was filed for DESIGN PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the DESIGN PHARMACEUTICALS trademark a serial number of 88901981. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, January 19, 2021. This trademark is owned by Design Pharmaceuticals Inc.. The DESIGN PHARMACEUTICALS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Drug discovery services; biological research; clinical research in the medical, pharmaceutical, and biotechnology fields; medical research; research on the subject of pharmaceuticals; scientific research for medical purposes in the area of cancerous diseases; research and development in the pharmaceutical and biotechnology fields; research and development in the pharmaceutical and biotechnology fields for the pharmaceutical industry; pharmaceutical products development; medical laboratory services relating to the production of monoclonal antibodies; biomedical research services; medical and scientific research in the field of pharmacogenetics; research and development of vaccines and medicines; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; consulting services in the field research and development, namely, research and development of pharmaceutical therapeutics; consultancy relating to research and development in the field of therape...
General Information
Serial Number | 88901981 |
Word Mark | DESIGN PHARMACEUTICALS |
Filing Date | Tuesday, May 5, 2020 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Tuesday, January 19, 2021 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Drug discovery services; biological research; clinical research in the medical, pharmaceutical, and biotechnology fields; medical research; research on the subject of pharmaceuticals; scientific research for medical purposes in the area of cancerous diseases; research and development in the pharmaceutical and biotechnology fields; research and development in the pharmaceutical and biotechnology fields for the pharmaceutical industry; pharmaceutical products development; medical laboratory services relating to the production of monoclonal antibodies; biomedical research services; medical and scientific research in the field of pharmacogenetics; research and development of vaccines and medicines; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; consulting services in the field research and development, namely, research and development of pharmaceutical therapeutics; consultancy relating to research and development in the field of therapeutics; pharmaceutical research services |
Classification Information
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Sunday, May 17, 2020 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Design Pharmaceuticals Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Cambridge, MA 02139 |
Trademark Events
Event Date | Event Description |
Thursday, January 21, 2021 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Tuesday, January 19, 2021 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Monday, July 6, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, July 6, 2020 | NON-FINAL ACTION E-MAILED |
Monday, July 6, 2020 | NON-FINAL ACTION WRITTEN |
Thursday, June 25, 2020 | ASSIGNED TO EXAMINER |
Sunday, May 17, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Friday, May 8, 2020 | NEW APPLICATION ENTERED IN TRAM |